Article Details
Retrieved on: 2024-07-02 20:27:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes how the FDA's new regulation on laboratory-developed tests (LDTs) will ensure greater safety and accuracy in clinical pathology and medical diagnosis, particularly highlighted by issues during COVID-19 testing. MedTech industry insights are shared, noting potential industry resistance and congressional intervention.
Article found on: healthjournalism.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here